Purified rhIGF-I/rhIGFBP-3 complexes and their method of manufacture
US7968679B2 · kind B2 · utility
1Cited by
14References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2005 |
| Grant date | Jun 28, 2011 |
| Priority date | — |
| Expiry date | Jan 16, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4743
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Complexes of IGF-I and IGFBP-3 with new levels of purity are provided. Chromatographic techniques have been developed that remove contaminants, such as mass and charge variants of IGFBP-3. The new techniques enable the production of high-quality pharmaceutical compositions comprising IGF-I/IGFBP-3 complexes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.